Both companies are committing to transforming and scaling AI skilling and learning for learners,workers,and employers
New ZX10 boasts powerful AI-ready performance,intuitive Android functionality,and fully rugged reliability,making it ideally suited to challenging field-based tasks
XingImaging Opens State-of-the-Art Research Facility in New Haven, Connecticut
NEW HAVEN,Conn.,Jan. 13,2025-- XingImaging,a MITRO company,a leader in advanced research imaging and radiopharmaceutical services,is excited to announce the opening of its new state-of-the art resear
BELLEVUE,Wash.,Jan. 13,2025-- Anker Innovations,a global leader in mobile charging and consumer electronics,today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Sh
BEIJING,Jan. 13,2025--China Liberal Education Holdings Limited ("China Liberal" or the "Company") (NASDAQ:CLEU),a China-based company that provides technological consulting service
Redefining Charging: Anker Innovations Showcases Smart and Sustainable Solutions at CES
BELLEVUE,Wash.,Jan. 13,2025-- Anker Innovations,a global leader in mobile charging and consumer electronics,today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Sh
Scintimun® Commercialization Partnership with Curium Pharma
MELBOURNE,Australiaand LIÈGE,Belgium,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has entered into an agreement with Curium Ph
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.
Gianna Lullume Baby Soother Device Officially Launches on Kickstarter
HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody